BERLIN: It’s no secret that Donald Trump is obsessed with winning the Nobel Peace Prize, which is one reason why he’s pushing Ukraine and Russia so hard towards ceasefire negotiations.

On Tuesday, Boehringer Ingelheim’s Empagliflozin became off-patent in India. Major domestic drugmakers are expected to launch their generic versions soon. According to the company’s statement ...

The motivation reads: The prize is awarded for their groundbreaking research and strong business acumen, contributing to an important innovation in the fight against Alzheimer's disease and for ...

The 15 th Orange Social Venture Prize in Africa and the Middle East is open for submissions. Candidates from the 17 countries within the Orange footprint have until 18 May to submit their project on ...

As the construction industry intensifies its efforts towards sustainability, architects and developers are actively seeking innovative solutions to reduce the environmental footprint of buildings ...

To put this into perspective, the ICC Champions Trophy prize money is $2.24 million (₹20 crore)—which means Hardik’s wristwear is worth almost the same as the grand prize for winning the entire ...

(Image Credits: Pixabay) Boehringer Ingelheim’s blockbuster diabetes drug, Empagliflozin, is now off-patent in India, paving the way for domestic drugmakers to launch generic versions.

Learn more at https://www.boehringer-ingelheim.com. About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and ...

Veldhoven (the Netherlands) and Leuven (Belgium), March 11, 2025 – ASML Holding N.V. (ASML) and imec, a leading research and innovation hub in nanoelectronics and digital technologies ...

The WMF - We Make Future confirms its status as a global reference point for innovation with today's announcement of over 160 speakers, a small preview of the speakers expected, over 1.000—true ...